Open to everyone and updated weekly, the OMMBID blog provides a forum for geneticists, genetics researchers, educators, and students to debate and share information on the latest advances in the field. In addition, select postings highlight recent updates and new features in Scriver’s OMMBID.
Blog contributors can buttress their arguments by linking to related abstracts or chapters in Scriver’s OMMBID. OMMBID subscribers have access to full-length chapters, while non-subscribers may purchase pdf versions of individual chapters on a pay-per-view basis.
Please note that Scriver’s OMMBID blog is moderated. Items contributed to the blog do not post immediately. All contributions are screened prior to posting to ensure that spam, obscenities, or other inappropriate items do not appear on the site. Contributions are not screened on the basis of their intellectual content. We encourage contributors to freely discuss and debate.
DAVID VALLE, M.D.
Henry J. Knott Professor and Director, McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
CHARLES R. SCRIVER, CC, GOQ, GM, MDCM, DSc (Hon), FRS, FRSC
Dr. Scriver is currently Professor Emeritus of Pediatrics, Biochemistry (Associate), Biology (Honorary) and Human Genetics in the Faculties of Medicine and Science at McGill University and Alva Professor Emeritus of Human Genetics.
Dr. Scriver was co-director and then Director of the Medical Research Council Group in Genetics until 1994, and co-Director of the Canadian Genetic Diseases Network (Network of Centers of Excellence) until 1997. He was Senior Editor of The Metabolic and Molecular Bases of Inherited Disease (now Online: OMMBID) which received the 1995 Medical Book Award (American Medical Writers Assoc) for the best book in its category.
PHILIPPE CAMPEAU, M.D., FRCPC (Medical Genetics)
As the administrator for Scriverâ€™s OMMBID blog, Dr. Campeau fosters intellectual discussion on the site. He completed his medical studies at Laval University, Canada, and a five year residency in Medical Genetics at McGill University. He is currently undertaking a postdoctoral research fellowship at the Baylor College of Medicine, in Houston, Texas. Dr. Campeauâ€™s research focuses on the treatment of inborn errors of metabolism.
NICOLA BRUNETTI-PIERRI, MD, FACMG
Dr. Brunetti-Pierri completed his Medical School and Pediatrics residency at Federico II University of Naples, Italy. He performed research training and trainings in Clinical Genetics and Clinical Biochemical Genetics in the Department of Molecular and Human Genetics of Baylor College of Medicine, Houston, USA. He is currently assistant professor in the Department of Pediatrics of Federico II University of Naples, Italy and his research laboratory is based at the Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy. His research is focused on gene therapy and small molecule therapy for inborn errors of metabolism.
HILARY J. TINKEL VERNON, MD PhD
Dr. Vernon is Assistant Professor at the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins University Medical School and a biochemical geneticist at the Metabolism Clinic and Biochemical Laboratory at the Kennedy Krieger Institute in Baltimore, Maryland. Her research is currently focused on understanding the primary and secondary biochemical disturbances in multiple inborn errors of metabolism. She earned her MD at Robert Wood Johnson Medical School/UMDNJ and her PhD in molecular Genetics at Rutgers University with Jay Tischfield, PhD.
YANNIS TRAKADIS, MD, MSc
Dr. Trakadis is Assistant Professor in Human Genetics at McGill University. He is a medical geneticist and metabolics physician at the McGill University Health Centre, covering both pediatrics and adults. Dr. Trakadis completed his MD and clinical genetics training, including post-doctoral clinical training in pediatrics and internal medicine, at McGill. His training also includes a BSc in Biochemistry, a Masters in Human Genetics, and a CCMG fellowship in biochemical genetics. Dr. Trakadis’ research focus lies on inborn errors of metabolism associated with cognitive and neuropsychiatric impairment, particularly in adolescents and adults.
Alina Levtova, MD, FRCPC (Medical Genetics)
After receiving her medical degree from McGill University, Dr. Levtova completed a residency program in clinical genetics and is currently undertaking CCMG sub-specialization training in Clinical and Laboratory Biochemical Genetics at the University of Montreal. She is particularly interested in neurometabolic disorders and in the treatment of inborn errors of metabolism.